Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Transduction01:16

Transduction

21
Among the three main modes of HGT—transformation, conjugation, and transduction—transduction is unique in that it is mediated by bacteriophages, or bacterial viruses.Transduction occurs in two ways. Generalized transduction occurs during the lytic cycle of a bacteriophage infection. In this process, bacteriophages infect bacterial cells, replicate within them, and ultimately cause cell lysis, releasing newly assembled virions. Occasionally, random fragments of the bacterial genome...
21

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Enhancing clinical utility of AI-based antimicrobial resistance models: a perspective.

mBio·2026
Same author

Standardized numbering and alignment of the KPC family of β-lactamases.

Antimicrobial agents and chemotherapy·2026
Same author

Resistance to novel β-lactam/β-lactamase inhibitors among carbapenem-resistant <i>Pseudomonas aeruginosa</i> and clinical implications in the prospective observational <i>Pseudomonas</i> study.

Antimicrobial agents and chemotherapy·2026
Same author

Sulbactam-durlobactam and cefiderocol combination treatment of <i>Burkholderia cenocepacia</i>-associated Fitz-Hugh-Curtis syndrome.

Antimicrobial agents and chemotherapy·2026
Same author

Role of Ambler Position 104 in Defining Substrate Specificity in the KPC Family of β-Lactamases.

ACS infectious diseases·2026
Same author

A Val292 substitution combined with an alanine duplication (ADUP) in the Ω loop of ADC β-lactamase confers reduced susceptibility to advanced β-lactam agents, including cefiderocol.

mBio·2026

相关实验视频

Updated: Jul 12, 2025

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
09:16

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

Published on: March 25, 2020

7.3K

针对NDM-1的指导演变.

Caitlyn A Thomas1, Zishuo Cheng1, Christopher R Bethel2

  • 1Department of Chemistry and Biochemistry, Miami University , Oxford, Ohio, USA.

Antimicrobial agents and chemotherapy
|October 24, 2023
PubMed
概括

新德里金属β-乳糖酶 (NDM-1) 变种没有通过氨基酸变化增加对美罗的耐药性. 在临床环境中,增加转录或改变运输可能对美罗胺耐药性更为关键.

关键词:
在NDM-1中,它是NDM-1.抗生素耐药性 抗生素耐药性抗微生物耐药性 抗微生物耐药性贝塔 - 乳糖酶酶的存在贝塔乳糖类药物 贝塔乳糖类药物耐药性的演变 药物耐药性的演变

更多相关视频

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
09:01

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli

Published on: March 16, 2011

30.6K
A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
13:30

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

18.1K

相关实验视频

Last Updated: Jul 12, 2025

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity
09:16

In Vitro Directed Evolution of a Restriction Endonuclease with More Stringent Specificity

Published on: March 25, 2020

7.3K
Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli
09:01

Mutagenesis and Functional Selection Protocols for Directed Evolution of Proteins in E. coli

Published on: March 16, 2011

30.6K
A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes
13:30

A New Screening Method for the Directed Evolution of Thermostable Bacteriolytic Enzymes

Published on: November 7, 2012

18.1K

科学领域:

  • 微生物学 微生物学
  • 酶学 是一种酶学.
  • 药物耐药性 药物耐药性 药物耐药性

背景情况:

  • β-乳酸抗生素是关键的治疗方法,但耐药性是一个越来越令人担忧的问题.
  • β-乳酸酶,特别是金属β-乳酸酶 (MBLs),是通过化β-乳酸胺键来赋予耐药性的关键酶.
  • 新德里金属β-乳糖酶 (NDM-1) 是一种临床显著的MBL,需要进一步研究.

研究的目的:

  • 为了研究NDM-1β-乳酸酶的体外蛋白质演变.
  • 确定NDM-1中氨基酸替代是否可以增强对美罗胺的耐药性.

主要方法:

  • 利用易发生错误的聚合酶链反应产生NDM-1变体.
  • 评估了生成的变体对美罗胺的耐药性概况.

主要成果:

  • 在NDM-1变种中没有观察到氨基酸替代,从而增加了对美罗胺的耐药性.
  • 通过氨基酸变化的蛋白质进化似乎不是NDM-1对美罗胺耐药性的主要驱动因素.

结论:

  • 在NDM-1中氨基酸替代不太可能是增加美罗胺耐药性的主要机制.
  • 替代机制,如增加基因转录或改变离子运输,需要进一步调查NDM-1介导耐药性的临床相关性.